The CMMID has a number of faculty members with national and international reputation in their fields. This center is unique in that it is the only one in the university whose primary objective is the use of molecular biotechnology and immunological techniques in the development of diagnostic tests, vaccines, and that addresses basic problems of infectious, immunological, and biochemical diseases of humans and animals.
There are commercial vaccines for the prevention of hemorrhagic enteritis virus (turkeys), porcine circovirus (SuvxyanTM PCV2 One Dose, swine) and brucellosis (Brucella abortus RB51TM, cattle) that have been developed at CMMID and used nationally and internationally.
An essential infrastructure facility to accomplish some of the objectives of CMMID is the presence of two biosafety level-3 (BSL-3) laboratories and adjoining ABSL-3 animal quarters that are located in the infectious disease unit of the center. Thus the center can work with a variety of pathogens in the laboratory or in infected animals in a safe manner.
The faculty at the CMMID are actively working in the following areas:
Postdoctoral fellows, research associates, graduate students, and a limited number of honors and undergraduate students work with the faculty members on research projects. Students are trained at both the master in science and doctoral degree levels to pursue careers in biomedical science in academics, industry, and government. Undergraduate students from colleges throughout the university work with faculty members to obtain experience in basic and applied research.